Goldman Sachs’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
DTC
Goldman Sachs's WGS Position: Q2 2026 in Review
Goldman Sachs increased its GeneDx Holdings (WGS) stake by 25% in Q2 2026, buying an estimated $19M and bringing the position to 1,669,441 shares worth $115M. The position accounts for 0.01% of the portfolio, ranked #1129.
Goldman Sachs first reported a position in WGS in Q4 2020 and has held it in 21 quarters since. The position peaked at $159M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Goldman Sachs held 1,669,441 shares of GeneDx Holdings worth $115M as of Q2 2026.
- Goldman Sachs bought 334,461 GeneDx Holdings shares in Q2 2026, an estimated $19M.
- GeneDx Holdings made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1129 holding.
- Goldman Sachs first reported a position in GeneDx Holdings in Q4 2020 and has held it in 21 quarters since.
- Goldman Sachs's GeneDx Holdings position peaked at $159M in Q4 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.